Sydney Adventist Hospital 02 9487 9111


Sydney Adventist Hospital
« View pages

Clinical Specialties

Lung Cancer Clinical Trials

IMpower 

GO29438 A Phase III, Open-label, randomized study of Atezolizumab (MPDL3280A, Anti PD-L1 Antibody) in combination with Carboplatin or Cisplatin + Pemetrexed compared with Carboplatin or Cisplatin + Pemetrexed in patients who are chemotherapy-naive and have Stage IV Non-Squamous Non-Small Cell Lung Cancer

https://clinicaltrials.gov/ct2/show/NCT02657434?term=GO+29438&rank=1

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services